News – Page 352 – Endpoints News

'Inspired' by Ipsen's mission, Sandra Silvestri joins as next CMO; Exicure's slide continues with CEO, CFO exits

3 years ago

Updated: FDA approves Pfizer’s Prevnar 20 for infants and children

3 years ago

FDA to review Takeda's BLA resubmission for subcutaneous UC drug Entyvio after 2019 rejection

3 years ago

Eli Lilly will use a priority review voucher on Mounjaro to 'remove any uncertainty' around fast FDA review

3 years ago

Research startup Care Access lays off half of staff following Pfizer Lyme trial woes

3 years ago

Updated: AbbVie axes two candidates as company revenue drops nearly 10%

3 years ago

Rhodium Scientific pursues manufacturing efforts in space

3 years ago

Manufacturing roundup: WHO issues another alert for cough syrup contamination; BioCina gets grant from Australia

3 years ago

Amid bankruptcy, Akorn is pulling dozens of generic products off the shelves

3 years ago

Zevra CEO and two others lose board re-election as small shareholder prevails with his nominees

3 years ago

Quest Diagnostics buys Bert Vogelstein’s Haystack Oncology, just six months after Series A

3 years ago

One SPAC inks biotech merger, while another linked to former Biden cancer moonshot leader will shut down

3 years ago

4DMT unveils dose exploration data in wet AMD; Exicure installs new C-suite exec

3 years ago

Astellas, Supernus and Patrick Dempsey take the stage at Publicis Health Media’s HealthFront

3 years ago

Foresight Diagnostics' approach for the earlier detection of cancer recurrence pulls in nearly $59M

3 years ago

Celularity ends clinical trial, to now focus on new NK cell therapy amid cash crunch

3 years ago

Pattern Bioscience raises $28.7M Series C for faster, more efficient antibiotic resistance test

3 years ago

MD Anderson, Flagship startup partner to design and test cancer drugs made with generative AI

3 years ago

Sanofi scraps topical BTK drug from $3.7B Principia buyout

3 years ago

Sangamo cuts 120 jobs, announces prioritized pipeline to extend cash runway another year

3 years ago

Eli Lilly showcases PhIII weight loss data for type 2 diabetes patients taking tirzepatide

3 years ago

‘Sleeping blockbuster’: MPM leads $53M Series E for Antiva as biotech seeks second go at tackling HPV

3 years ago

AstraZeneca cuts Alexion's PhIII Wilson disease drug, takes $244M writedown

3 years ago

Exclusive: Therini raises $36M, will target fibrin protein for Alzheimer's and diabetic macular edema

3 years ago

First page Previous page 349 350 351352353 354 355 Next page Last page